Opinion statement
Advances in medical therapy and non-surgical percutaneous options to manage the specter of acute aortic syndromes have improved both patient morbidity and mortality. There are key features in the patient history and initial exam which physicians should be attuned to in order to diagnose acute aortic syndromes such as aortic dissection, penetrating aortic ulcer, and intramural hematoma. Once recognized, early initiation of the appropriate pharmacologic therapy is important, and further appreciating the limitations of such therapy before considering a surgical approach is critical to improve patient outcomes. For the undifferentiated patient with acute aortic dissection presenting to facilities who do not routinely manage this condition, adding pharmacologic agents in the correct sequence assures the best chance for a satisfactory outcome.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
•• Mussa FF et al. Acute aortic dissection and intramural hematoma: a systematic review. JAMA. 2016;316(7):754–63. This manuscript offers a current, concise summary of what constitutes an acute aortic syndrome, including summaries of major clinical trials.
Tsai TT, Nienaber CA, Eagle KA. Acute aortic syndromes. Circulation. 2005;112(24):3802–13.
Howard DP et al. Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study. Circulation. 2013;127(20):2031–7.
Nienaber CA, Powell JT. Management of acute aortic syndromes. Eur Heart J. 2012;33(1):26–35b.
Kawabori M, Kaneko T. Acute aortic syndrome: a systems approach to a time-critical disease. Best Pract Res Clin Anaesthesiol. 2016;30(3):271–81.
Harris KM et al. Acute aortic intramural hematoma: an analysis from the International Registry of Acute Aortic Dissection. Circulation. 2012;126(11 Suppl 1):S91–6.
Debakey ME et al. Surgical management of dissecting aneurysms of the aorta. J Thorac Cardiovasc Surg. 1965;49:130–49.
Daily PO et al. Management of acute aortic dissections. Ann Thorac Surg. 1970;10(3):237–47.
Sun ZH. Abdominal aortic aneurysm: treatment options, image visualizations and follow-up procedures. J Geriatr Cardiol. 2012;9(1):49–60.
Beaulieu RJ, et al. Surgical management of peripheral vascular manifestations of Loeys-Dietz syndrome. Ann Vasc Surg, 2016; 1–7
Kalkat MS et al. Presentation and outcome of Marfan’s syndrome patients with dissection and thoraco-abdominal aortic aneurysm. Eur J Cardiothorac Surg. 2007;32(2):250–4.
Regalado E et al. Autosomal dominant inheritance of a predisposition to thoracic aortic aneurysms and dissections and intracranial saccular aneurysms. Am J Med Genet A. 2011;155A(9):2125–30.
Nienaber CA et al. Aortic intramural haematoma: natural history and predictive factors for complications. Heart. 2004;90(4):372–4.
von Kodolitsch Y, Csösz S, Koschyk DH, Schalwat I, Loose R, Karck M, et al. Intramural hematoma of the aorta: predictors of progression to dissection and rupture. Circulation. 2003;107(8):1158–63.
Stanson AW et al. Penetrating atherosclerotic ulcers of the thoracic aorta: natural history and clinicopathologic correlations. Ann Vasc Surg. 1986;1(1):15–23.
Cooke JP, Kazmier FJ, Orszulak TA. The penetrating aortic ulcer: pathologic manifestations, diagnosis, and management. Mayo Clin Proc. 1988;63(7):718–25.
Coady MA, Rizzo JA, Elefteriades JA. Pathologic variants of thoracic aortic dissections. Penetrating atherosclerotic ulcers and intramural hematomas. Cardiol Clin. 1999;17(4):637–57.
Andersen ND et al. Outcomes of acute type a dissection repair before and after implementation of a multidisciplinary thoracic aortic surgery program. J Am Coll Cardiol. 2014;63(17):1796–803.
Harris KM et al. Multidisciplinary standardized care for acute aortic dissection: design and initial outcomes of a regional care model. Circ Cardiovasc Qual Outcomes. 2010;3(4):424–30.
Hagan PG et al. The International Registry of Acute Aortic Dissection (IRAD). JAMA. 2000;283(7):897.
Chan KK, Lai P, Wright JM. First-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissections. Cochrane Database Syst Rev. 2014;2:1–9.
LeMaire SA, Russell L. Epidemiology of thoracic aortic dissection. Nat Rev Cardiol. 2011;8(2):103–13.
Silaschi M, Byrne J, Wendler O. Aortic dissection: medical, interventional and surgical management. Heart. 2016. Epub ahead of print
Robbins RC et al. Management of patients with intramural hematoma of the thoracic aorta. Circulation. 1993;88(5 Pt 2):II1–II10.
Evangelista A et al. Acute intramural hematoma of the aorta: a mystery in evolution. Circulation. 2005;111(8):1063–70.
Girardi LN, Al’Aref SJ, Devereux R, Lau C, Ghosh BD. Swaminathan RV. A contemporary review of acute aortic dissection. Emergency Medicine: Open Access. 2015;05(05):1–10.
Suzuki T et al. Clinical profiles and outcomes of acute type B aortic dissection in the current era: lessons from the International Registry of Aortic Dissection (IRAD). Circulation. 2003;1 Suppl 1:II312-7.
•• Erbel R et al. ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(41):2873–926. This manuscript is the most up-to-date, concise consensus statement focusing on detection, diagnosis, and monitoring of patients with acute aortic syndromes. It is particularly useful is guiding surveillance for patients with congenital aortopathies.
Hiratzka LF et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol. 2010;55(14):e27–e129.
Suzuki T et al. Type-selective benefits of medications in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD]). Am J Cardiol. 2012;109(1):122–7.
Sakakura K et al. Determinants of long-term mortality in patients with type B acute aortic dissection. Am J Hypertens. 2009;22(4):371–7.
Takeshita S et al. Angiotensin-converting enzyme inhibitors reduce long-term aortic events in patients with acute type B aortic dissection. Circ J. 2008;72(11):1758–61.
Owens 3rd AP et al. Platelet inhibitors reduce rupture in a mouse model of established abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 2015;35(9):2032–41.
Schouten O et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg. 2006;32(1):21–6.
Wemmelund H et al. Statin use and rupture of abdominal aortic aneurysm. Br J Surg. 2014;101(8):966–75.
Saborio DV et al. Management of intramural hematoma of the ascending aorta and aortic arch: the risks of limited surgery. Tex Heart Inst J. 2003;30(4):325–7.
Li DL et al. Acute type B aortic intramural hematoma: treatment strategy and the role of endovascular repair. J Endovasc Ther. 2010;17(5):617–21.
Zhang G, Feng Q, Zheng D. Early aggressive medical treatment associatd with selective prophylactic aortic stent-grafting for aortic intramural hematoma. Thorac Cardiovasc Surg. 2011;59(6):342–8.
Canadas MV et al. Intramural aortic hematoma and anticoagulation. Rev Esp Cardiol. 2007;60(2):201–4.
El Hassani I et al. Penetrating atherosclerosis aortic ulcer: a re-appraisal. Acta Chir Belg. 2016;3:1–7.
Patatas K, Shrivastava V, Ettles DF. Penetrating atherosclerotic ulcer of the aorta: a continuing debate. Clin Radiol. 2013;68(8):753–9.
Ganaha F et al. Prognosis of aortic intramural hematoma with and without penetrating atherosclerotic ulcer:a clinical and radiological analysis. Circulation. 2002;106:342–8.
Fattori R et al. Complicated acute type B dissection: is surgery still the best option?: a report from the International Registry of Acute Aortic Dissection. JACC Cardiovasc Interv. 2008;1(4):395–402.
Booher AM et al. Ascending thoracic aorta dimension and outcomes in acute type B dissection (from the International Registry of Acute Aortic Dissection [IRAD]). Am J Cardiol. 2011;107(2):315–20.
Nienaber CA et al. Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv. 2013;6(4):407–16.
Muehle A et al. Experiences with ascending aortic endografts using FDA IDE approved devices. What has been done, what lesions can be treated and what challenges remain. J Cardiovasc Surg (Torino). 2015;56(1):11–8.
• Cambria RP, Conrad MF. Thoracic endovascular aneurysm repair for uncomplicated type B dissection. J Vasc Surg. 2016;64(6):1558–9. At the time of writing this review, this article summarizes endovascular options for managing Type B aortic dissections with available evidence.
• Durham CA et al. The natural history of medically managed acute type B aortic dissection. J Vasc Surg. 2015;61(5):1192–8. This article is a large registry spanning more than a decade which describes the outcomes in patients managed medically for Type B Aortic Dissections. This article is useful in appreciating the surgeon's viewpoint of medical management for Type B Aortic Dissection.
Scali ST et al. Efficacy of thoracic endovascular stent repair for chronic type B aortic dissection with aneurysmal degeneration. J Vasc Surg. 2013;58(1):10-7 e1.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Vascular Disease
Rights and permissions
About this article
Cite this article
Morris, J.H., Mix, D. & Cameron, S.J. Acute Aortic Syndromes: Update in Current Medical Management. Curr Treat Options Cardio Med 19, 29 (2017). https://doi.org/10.1007/s11936-017-0523-9
Published:
DOI: https://doi.org/10.1007/s11936-017-0523-9